Immunogen
Recombinant fragment contain a sequence corresponding to a region within amino acids 1 and 498 of Influenza A Virus H1N1 NP
Application
Suggested starting dilutions are as follows: ICC/IF: 1:100-1:1000, WB: 1:1000-1:10000. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user.
Features and Benefits
Evaluate our antibodies with complete peace of mind. If the antibody does not perform in your application, we will issue a full credit or replacement antibody. Learn more.
Physical form
Phosphate-buffered saline, no preservative added.
Other Notes
Purification: Affinity purified by Protein G
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
| biological source | mouse |
| Quality Level | 100 |
| conjugate | unconjugated |
| antibody form | affinity isolated antibody |
| antibody product type | primary antibodies |
| clone | GT1236, monoclonal |
| form | buffered aqueous solution |
| mol wt | 56kDa |
| species reactivity | influenza A virus |
| technique(s) | immunofluorescence: 1:100-1:1,000,immunohistochemistry: suitable,western blot: 1:1,000-1:10,000 |
| isotype | IgG2b |
| shipped in | wet ice |
| storage temp. | −20°C |
| target post-translational modification | unmodified |
